# OnCo record paper-adiuvo-adjuvant-mitotane-low-grade-acc-terzolo-lancet-diabetes-endocrinol-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-adiuvo-adjuvant-mitotane-low-grade-acc-terzolo-lancet-diabetes-endocrinol-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-adiuvo-adjuvant-mitotane-low-grade-acc-terzolo-lancet-diabetes-endocrinol-2023" ;
  schema:name "ADIUVO: adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma"@en ;
  schema:description "After complete removal of a low-grade adrenal cancer, two years of mitotane did not significantly reduce recurrence or improve survival compared with surveillance, and every patient on it had side effects."@en ;
  schema:url <https://onco.cc/key-papers/paper-adiuvo-adjuvant-mitotane-low-grade-acc-terzolo-lancet-diabetes-endocrinol-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S2213-8587(23)00193-6>, <https://pubmed.ncbi.nlm.nih.gov/37619579/> ;
  schema:sameAs <https://doi.org/10.1016/S2213-8587(23)00193-6> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Terzolo M, Fassnacht M, Perotti P, et al." ;
  onco:cancers <https://onco.cc/cancers/localised-adrenocortical-carcinoma/>, <https://onco.cc/cancers/adrenocortical/> ;
  onco:drugs <https://onco.cc/drugs/mitotane/> ;
  onco:trials <https://onco.cc/trials/adiuvo/> .